Nonetheless, increased serum levels of CRP and TNF-α have been detected in women as early as 5 years prior to the time of ovarian cancer diagnosis, although there is uncertainty as to whether these markers are reflective of local site inflammation pertinent to the ovarian tumor microenvironment [56]. The gene discussed is TNF; the disease is ovarian carcinoma.